Correlation Between Candel Therapeutics and PaxMedica, Common

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and PaxMedica, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and PaxMedica, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and PaxMedica, Common Stock, you can compare the effects of market volatilities on Candel Therapeutics and PaxMedica, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of PaxMedica, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and PaxMedica, Common.

Diversification Opportunities for Candel Therapeutics and PaxMedica, Common

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between Candel and PaxMedica, is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and PaxMedica, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PaxMedica, Common Stock and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with PaxMedica, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PaxMedica, Common Stock has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and PaxMedica, Common go up and down completely randomly.

Pair Corralation between Candel Therapeutics and PaxMedica, Common

If you would invest  776.00  in Candel Therapeutics on September 18, 2024 and sell it today you would lose (160.00) from holding Candel Therapeutics or give up 20.62% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy1.59%
ValuesDaily Returns

Candel Therapeutics  vs.  PaxMedica, Common Stock

 Performance 
       Timeline  
Candel Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Candel Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady fundamental indicators, Candel Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.
PaxMedica, Common Stock 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PaxMedica, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, PaxMedica, Common is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Candel Therapeutics and PaxMedica, Common Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Candel Therapeutics and PaxMedica, Common

The main advantage of trading using opposite Candel Therapeutics and PaxMedica, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, PaxMedica, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PaxMedica, Common will offset losses from the drop in PaxMedica, Common's long position.
The idea behind Candel Therapeutics and PaxMedica, Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals